Fresenius Medical Care AG & Co. KGaA

(NYSE:FMS)

Latest On Fresenius Medical Care AG & Co. KGaA (FMS):

Date/Time Type Description Signal Details
2024-05-17 05:58 ESTDividendA dividend of $0.63 has been announced on Apr 15, 2024. It will be paid Jun 3, 2024 with an ex-dividend date of May 17, 2024.Neutral
2023-05-26 04:49 ESTNewsFresenius sees brighter days for pharma division KabiN/A
2023-05-17 05:57 ESTDividendA dividend of $0.62 has been announced on May 3, 2023. It will be paid Jun 1, 2023 with an ex-dividend date of May 17, 2023.Neutral
2023-05-09 21:01 ESTNewsFresenius Medical Care AG & Co. KGaA (FMS) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 06:47 ESTNewsFresenius Q1 operating income drop softened by easing labor shortage; deconsolidation on trackN/A
2023-03-21 13:10 ESTNewsFresenius Medical Care: Attractive Post Crash, Maintaining A 'Buy' RatingN/A
2023-02-22 20:16 ESTNewsFresenius Medical Care AG & Co. KGaA 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-22 20:16 ESTNewsFresenius Medical Care AG & Co. KGaA (FMS) Q4 2022 Earnings Call TranscriptN/A
2023-02-22 07:16 ESTNewsFresenius stock rises as Q4 revenue grows, plans restructuring; sees 'headwinds' in FY23N/A
2023-02-21 18:45 ESTNewsFresenius Medical Care Q4 2022 Earnings PreviewN/A
2023-02-09 18:36 ESTNewsFresenius considering deconsolidating dialysis subsidiary - BloombergN/A
2023-01-06 19:18 ESTNewsFresenius: The Company Is Climbing, And I'm At 'Buy'N/A
2022-12-06 11:18 ESTNewsFresenius Medical Care CFO takes over as CEO amid focus on 'operational turnaround'N/A
2022-11-01 02:52 ESTNewsFresenius under pressure to make changes as activist Elliott takes 3% stake - BloombergN/A
2022-11-01 02:52 ESTNewsFresenius Medical Care AG & Co. KGaA (FMS) Q3 2022 Earnings Call TranscriptN/A
2022-10-31 10:36 ESTNewsFresenius Q3 net income falls amid labor market woes, cuts FY22 outlook on slower recoveryN/A
2022-10-31 10:35 ESTNewsFresenius Medical Care AG & Co. KGaA 2022 Q3 - Results - Earnings Call PresentationN/A
2022-10-27 18:07 ESTNewsFresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)N/A
2022-10-19 18:05 ESTNewsFresenius Medical gains after report of activist Elliott stake in Fresenius SEN/A
2022-10-10 19:51 ESTNewsFresenius cut to Hold at Jefferies citing staffing issues and inflationN/A
2022-08-31 05:50 ESTNewsFresenius gets award to provide dialysis services to U.S. military veteransN/A
2022-08-21 01:47 ESTNewsFresenius appoints head of pharma unit as new CEON/A
2022-08-19 05:43 ESTNewsFresenius: Too Cheap, Measured By Sum-Of-The-PartsN/A
2022-07-30 11:07 ESTNewsFresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend AristocratN/A
2022-07-28 17:20 ESTNewsFresenius stock slumps 13% as labor costs, inflation impact leads to FY22 outlook cut; 2025 targets withdrawnN/A
2022-07-14 00:09 ESTNewsFresenius slips as U.S. joins whistleblower lawsuit over Medicare fraudN/A
2022-06-19 10:01 ESTNewsFresenius: Revisiting The Thesis - Still A BuyN/A
2022-05-13 05:58 ESTDividendA dividend of $0.71 has been announced on Apr 28, 2022. It will be paid May 27, 2022 with an ex-dividend date of May 13, 2022.Neutral
2022-05-04 16:46 ESTNewsFresenius Medical Care Non-GAAP EPS of €0.68, revenue of €4.55BN/A
2022-05-04 16:46 ESTNewsFresenius Medical Care AG & Co. (FMS) CEO Rice Powell on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 00:06 ESTNewsFresenius Medical names Carla Kriwet as next CEON/A
2022-05-02 12:10 ESTNewsFresenius: The Upside Is Getting BiggerN/A
2022-03-31 22:53 ESTNewsFresenius Kabi bolsters biosimilar, infusion businesses with mAbxience and Ivenix dealsN/A
2022-02-23 09:19 ESTNewsFresenius Medical Care AG & Co. KGaA. (FMS) CEO Rice Powell on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-22 14:15 ESTNewsFresenius Medical Care Non-GAAP EPS of €0.90, revenue of €4.64BN/A
2022-02-09 23:34 ESTNewsFresenius Medical Care: World Leader In Dialysis, But Still Not ExcitingN/A
2021-12-01 13:22 ESTNewsFresenius Medical Care announces company reorganizationN/A
2021-11-08 23:21 ESTNewsFresenius Medical Care reports Q3 resultsN/A
2021-11-03 03:44 ESTNewsFresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q3 2021 Results - Earnings Call TranscriptN/A
2021-09-22 13:49 ESTNewsFresenius Medical Care partners with JMS to advance home dialysis in JapanN/A
2021-09-10 12:19 ESTNewsFresenius Medical Care stock falls ~4% amid JPMorgan downgrade on COVID impactN/A
2021-08-28 14:57 ESTNewsYou Really Want To Know About Fresenius Medical CareN/A
2021-07-31 01:01 ESTNewsFresenius Medical Care AG & Co. KGaA 2021 Q2 - Results - Earnings Call PresentationN/A
2021-07-31 01:00 ESTNewsFresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-30 05:41 ESTNewsFresenius Medical Care misses on revenueN/A
2021-05-24 05:59 ESTDividendA dividend of $0.83 has been announced on Nov 30, -0001. It will be paid Jun 7, 2021 with an ex-dividend date of May 24, 2021.Neutral
2021-03-18 23:24 ESTAnalyst RatingThe Analyst Target Price has increased from $37.49 to $37.74.Buy
2021-03-17 22:28 ESTAnalyst RatingThe Analyst Target Price has decreased from $37.56 to $37.49.Neutral
2021-03-17 14:31 ESTAnalyst RatingThe Analyst Target Price has decreased from $37.65 to $37.56.Neutral
2021-03-17 13:39 ESTNewsFresenius Medical Care Appears To Be Fairly ValuedN/A

About Fresenius Medical Care AG & Co. KGaA (FMS):

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

See Advanced Chart

General

  • Name Fresenius Medical Care AG & Co. KGaA
  • Symbol FMS
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Care Facilities
  • Full Time Employees 125,364
  • Last Split Factor2:1
  • Last Split Date2012-12-04
  • Fiscal Year EndDecember
  • IPO Date1996-09-19
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Providers & Services
  • Gic SubIndustryHealth Care Services
  • Web URLhttp://www.freseniusmedicalcare.com
View More

Valuation

  • Trailing PE 9.88
  • Forward PE 13.18
  • Price/Sales (Trailing 12 Mt.) 1.01
  • Price/Book (Most Recent Quarter) 1.6
  • Enterprise Value Revenue 1.94
  • Enterprise Value EBITDA 8.4
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $2.16
  • Next Year EPS Estimate $2.40
  • Next Quarter EPS Estimate $0.69
  • Profit Margin 7%
  • Return on Assets 5%
  • Return on Equity 11%
  • Earnings Per Share $3.69
  • Revenue Per Share $0
  • Gross Profit 5.54 billion
  • Quarterly Earnings Growth -3.9%
View More

Highlights

  • Market Capitalization 21.37 billion
  • PEG Ratio 2.23
  • Analyst Target Price $37.74
  • Book Value Per Share $21.29
View More

Share Statistics

  • Shares Outstanding 585.75 million
  • Shares Float 396.99 million
  • % Held by Insiders <1%
  • % Held by Institutions 1.63%
  • Shares Short 995926
  • Shares Short Prior Month 360804
  • Short Ratio 1.42
View More

Technicals

  • Beta 0.96
  • 52 Week High $45.78
  • 52 Week Low $28.69
  • 50 Day Moving Average 36.07
  • 200 Day Moving Average 40.4
View More

Dividends

  • Forward Annual Dividend Rate $0.72
  • Forward Annual Dividend Yield 1.96%
  • Payout Ratio 26%
  • Dividend Date 2020-09-11
  • ExDividend Date 2020-08-28
  • Dividend Per Share $1.24
  • Dividend Yield 3.32%
View More

Fresenius Medical Care AG & Co. KGaA (FMS) Dividend Calendar:

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.72 per share, with a dividend yield of 3.32%.
FMS's last dividend payment was made to shareholders on September 11, 2020.
Fresenius Medical Care AG & Co. KGaA pays out 26% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Fresenius Medical Care AG & Co. KGaA (FMS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-23$N/A$0.77$0.80-3.85%
2020-09-302020-10-29$4.41 billion$0.71$0.6411.1%
2020-06-302020-07-30$4.56 billion$0.71$0.5431.36%
2020-03-312020-05-06$N/A$0.51$0.63-18.4%
2019-12-312020-02-20$5.14 billion$0.73$0.696.67%
2019-09-302019-10-29$4.82 billion$0.61$0.61-0.52%
2019-06-302019-07-30$4.9 billion$0.51$0.55-6.36%
2019-03-312019-05-02$4.63 billion$0.58$0.5114.34%
2018-12-312019-02-20$4.93 billion$0.65$0.65-0.14%
2018-09-302018-10-30$4.7 billion$0.57$0.64-10.2%
2018-06-302018-07-31$4.9 billion$0.52$0.62-16.54%
2018-03-312018-05-03$4.89 billion$0.48$0.61-21.61%
2017-12-312018-02-26$5.6 billion$0.73$0.6610.21%
2017-09-302017-11-02$5.48 billion$0.61$0.62-1.93%
2017-06-302017-08-01$5.43 billion$0.53$0.512.61%
2017-03-312017-05-03$4.87 billion$0.44$0.441.42%
2016-12-312017-02-22$4.69 billion$0.61$0.62-2.01%
2016-09-302016-10-27$4.6 billion$0.55$0.524.81%
2016-06-302016-08-01$4.42 billion$0.48$0.49-2.44%
2016-03-312016-05-03$4.21 billion$0.37$0.42-11.38%
2015-12-312016-02-24$4.35 billion$0.57$0.58-1.63%
2015-09-302015-10-29$4.23 billion$0.43$0.46-6.52%
2015-06-302015-07-30$4.2 billion$0.40$0.42-4.76%
2015-03-312015-04-29$3.96 billion$0.35$0.39-10.26%
2014-12-312015-02-25$4.32 billion$0.55$0.4912.24%
2014-09-302014-11-04$4.11 billion$0.45$0.442.27%
2014-06-302014-07-31$3.83 billion$0.42$0.412.44%
2014-03-312014-05-06$3.56 billion$0.34$0.38-10.53%
2013-12-312014-02-25$3.87 billion$0.59$0.5311.32%
2013-09-302013-11-05$3.67 billion$0.48$0.464.35%
2013-06-302013-07-30$3.61 billion$0.43$0.45-4.44%
2013-03-312013-04-30$3.46 billion$0.37$0.43-13.95%
2012-12-312013-02-26$3.71 billion$0.54$0.515.88%
2012-09-302012-10-31$3.42 billion$0.44$0.49-10.2%
2012-06-302012-08-01$3.43 billion$0.46$0.460%
2012-03-312012-05-03$3.25 billion$0.40$0.392.56%
2011-12-312012-02-21$3.26 billion$0.51$0.52-1.92%
2011-09-302011-11-02$3.18 billion$0.46$0.47-2.13%
2011-06-302011-08-02$3.14 billion$0.43$0.430%
2011-03-312011-05-04$2.98 billion$0.37$0.38-2.63%
2010-12-312011-02-23$3.17 billion$0.45$0.442.27%
2010-09-302010-11-02$3.06 billion$0.41$0.42-2.38%
2010-06-302010-08-03$2.95 billion$0.42$0.405%
2010-03-312010-05-04$2.88 billion$0.35$0.37-5.41%
2009-12-312010-02-24$3.04 billion$0.41$0.395.13%
2009-09-302009-11-03$2.89 billion$0.38$0.372.7%
2009-06-302009-08-04$2.76 billion$0.37$0.370%
2009-03-312009-04-30$2.56 billion$0.34$0.340%
2008-12-312009-02-19$2.72 billion$0.36$0.360%
2008-09-302008-11-04$2.71 billion$0.35$0.342.94%
2008-06-302008-07-30$2.67 billion$0.36$0.339.09%
2008-03-312008-04-30$2.51 billion$0.32$0.313.23%
2007-12-312008-02-20$2.57 billion$0.34$0.319.68%
2007-09-302007-10-30$2.43 billion$0.31$0.303.33%
2007-06-302007-08-02$2.4 billion$0.30$0.293.45%
2007-03-312007-05-02$2.32 billion$0.27$0.270%
2006-12-312007-02-22$2.35 billion$0.26$0.260%
2006-09-302006-10-31$2.23 billion$0.24$0.234.35%
2006-06-302006-08-03$2.17 billion$0.22$0.26-15.38%
2006-03-312006-05-03$1.75 billion$0.20$0.195.26%
2005-12-312006-02-22$1.77 billion$0.19
2005-09-302005-11-03$1.72 billion$0.20$0.200%
2005-06-302005-08-04$1.67 billion$0.20$0.200%
2005-03-312005-05-03$1.61 billion$0.19$0.20-5%
2004-12-312005-02-24$1.64 billion$0.19$0.20-5%
2004-09-302004-11-02$1.58 billion$0.18$0.18-1.83%
2004-06-302004-08-04$1.55 billion$0.17
2004-03-312004-05-06$1.46 billion$0.17
2003-12-312004-02-26$1.45 billion$0.17
2003-09-302003-11-04$1.41 billion$0.15
2003-06-302003-08-05$1.37 billion$0.15
2003-03-312003-05-07$1.3 billion$0.13
2002-12-312003-02-25$1.36 billion$0.14$0.137.69%
2002-09-302002-10-29$1.29 billion$0.12$0.120%
2002-06-302002-07-30$1.25 billion$0.13$0.130%
2002-03-312002-04-30$1.19 billion$0.13$0.14-7.14%
2001-12-312002-03-05$1.27 billion$0.11$0.110%
2001-09-302001-10-30$1.23 billion$0.11$0.12-8.33%
2001-06-302001-07-31$1.2 billion$0.11$0.110%
2001-03-312001-05-03$1.16 billion$0.10$0.11-9.09%
2000-12-312001-01-01$1.08 billion$0.11$0.110%
2000-09-302000-12-31$1.08 billion$0.11$0.110%
2000-06-302000-07-01$1.04 billion$0.10$0.11-9.09%
2000-03-312000-06-30$1 billion$0.10$0.11-9.09%
1999-09-301999-11-23$0.10$0.0911.11%
1999-06-301999-08-03$0.09$0.0812.5%
1999-03-311999-03-31$0.08
1998-12-311999-03-29$0.07$0.070%
1998-06-301998-07-23$0.04$0.06-33.33%
1997-09-301997-11-25$0.04$0.05-20%
1997-06-301997-08-27$0.07$0.070%
1997-03-311997-05-15$0.06$0.09-33.33%

Fresenius Medical Care AG & Co. KGaA (FMS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Fresenius Medical Care AG & Co. KGaA (FMS) Chart:

Fresenius Medical Care AG & Co. KGaA (FMS) News:

Below you will find a list of latest news for Fresenius Medical Care AG & Co. KGaA (FMS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Fresenius Medical Care AG & Co. KGaA (FMS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-08-15150CALL0 0164.53TRUE00
2025-08-1517.50CALL0 0127.79TRUE00
2025-08-15200CALL0 095.22TRUE00
2025-08-1522.55.35CALL0 3080.05TRUE00
2025-08-15250CALL0 070.86TRUE00
2025-08-15300CALL0 048.94FALSE00
2025-08-15350CALL0 0172.93FALSE00
2025-08-15400CALL0 0206.45FALSE00
2025-08-15150PUT0 0311.22FALSE00
2025-08-1517.50PUT0 0252.65FALSE00
2025-08-15200PUT0 0201.74FALSE00
2025-08-1522.50PUT0 0153.38FALSE00
2025-08-15250PUT0 068.18FALSE00
2025-08-15300PUT0 0128.26TRUE00
2025-08-15350PUT0 067.05TRUE00
2025-08-15400PUT0 091.89TRUE00
2025-09-19150CALL0 0123.62TRUE00
2025-09-1917.50CALL0 094.07TRUE00
2025-09-19200CALL0 080.99TRUE00
2025-09-1922.50CALL0 057.5TRUE00
2025-09-19250CALL0 046.35TRUE00
2025-09-19300CALL0 084.76FALSE00
2025-09-19350CALL0 0112.61FALSE00
2025-09-19400CALL0 0134.61FALSE00
2025-09-19150PUT0 0201FALSE00
2025-09-1917.50PUT0 0162.85FALSE00
2025-09-19200PUT0 0132.78FALSE00
2025-09-1922.50PUT0 0100.75FALSE00
2025-09-19250PUT0 072.66FALSE00
2025-09-19300PUT0 079.16TRUE00
2025-09-19350PUT0 0108.71TRUE00
2025-09-19400PUT0 045.16TRUE00
2025-10-1712.516.8CALL0 1138.43TRUE00
2025-10-171514.3CALL0 1121.59TRUE00
2025-10-1717.511.8CALL0 097.92TRUE00
2025-10-17209.3CALL0 779.68TRUE00
2025-10-1722.50CALL0 7567.77TRUE00
2025-10-17253.93CALL0 14650.72TRUE00
2025-10-17300CALL0 4156.03FALSE00
2025-10-17350.05CALL1 230.24FALSE0.050
2025-10-17400.1CALL0 10114.48FALSE00
2025-10-17450CALL0 0129.34FALSE00
2025-10-1712.50PUT0 0209.11FALSE00
2025-10-17150PUT0 0170.24FALSE00
2025-10-1717.50PUT0 0138.02FALSE00
2025-10-17200PUT0 0108.68FALSE00
2025-10-1722.50PUT0 583.33FALSE00
2025-10-17250PUT0 157.87FALSE00
2025-10-17300PUT0 034.79TRUE00
2025-10-17350PUT0 085.66TRUE00
2025-10-17400PUT0 0104.42TRUE00
2025-10-17450PUT0 059.62TRUE00
2026-01-16150CALL0 088.48TRUE00
2026-01-1617.50CALL0 071.14TRUE00
2026-01-16209.35CALL0 7067.86TRUE00
2026-01-1622.50CALL0 048.92TRUE00
2026-01-16253.9CALL0 2152.8TRUE00
2026-01-16301.7CALL0 3936.81FALSE00
2026-01-16350CALL0 069.3FALSE00
2026-01-16400CALL0 082.18FALSE00
2026-01-16450CALL0 041.97FALSE00
2026-01-16150PUT0 0119.74FALSE00
2026-01-1617.50PUT0 096.87FALSE00
2026-01-16200PUT0 076.95FALSE00
2026-01-1622.50PUT0 058.78FALSE00
2026-01-16251.98PUT0 341.18FALSE00
2026-01-16304.4PUT0 5514.2TRUE00
2026-01-16350PUT0 063.92TRUE00
2026-01-16400PUT0 080.91TRUE00
2026-01-16450PUT0 032.82TRUE00

Latest FMS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST23$26.55
Jun 13, 2022 7:59 PM EST13$26.565
Jun 13, 2022 7:59 PM EST100$26.585
Jun 13, 2022 7:59 PM EST100$26.585
Jun 13, 2022 7:59 PM EST100$26.585

Fresenius Medical Care AG & Co. KGaA (FMS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-2611-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1333141/000110465920077497/0001104659-20-077497-index.htm
2005-10-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1019600/000000000005053088/0000000000-05-053088-index.htm
2006-02-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1019600/000000000006008760/0000000000-06-008760-index.htm
2008-06-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1019600/000000000008027712/0000000000-08-027712-index.htm
2008-06-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1019600/000000000008027713/0000000000-08-027713-index.htm
2019-06-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1333141/000021545719008072/0000215457-19-008072-index.htm
2011-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1019600/000031506611002522/0000315066-11-002522-index.htm
2012-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1019600/000031506612002646/0000315066-12-002646-index.htm
2005-10-07F-4Registration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000095012305011984/0000950123-05-011984-index.htm
2005-10-11SC TO-ITender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1019600/000095012305012031/0000950123-05-012031-index.htm
2005-11-17F-4/ARegistration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000095012305013817/0000950123-05-013817-index.htm
2005-11-17SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1019600/000095012305013818/0000950123-05-013818-index.htm
2005-12-23F-4/ARegistration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000095012305015163/0000950123-05-015163-index.htm
2005-12-23SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1019600/000095012305015166/0000950123-05-015166-index.htm
2005-12-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1019600/000095012305015380/0000950123-05-015380-index.htm
2006-01-04F-4/ARegistration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000095012306000027/0000950123-06-000027-index.htm
2006-01-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1019600/000095012306000029/0000950123-06-000029-index.htm
2006-01-06424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1019600/000095012306000130/0000950123-06-000130-index.htm
2006-01-06SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1019600/000095012306000131/0000950123-06-000131-index.htm
2006-01-26424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1019600/000095012306000714/0000950123-06-000714-index.htm
2006-01-26SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1019600/000095012306000715/0000950123-06-000715-index.htm
2006-02-09SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1019600/000095012306001370/0000950123-06-001370-index.htm
2005-07-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605000791/0001019056-05-000791-index.htm
2005-08-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605000840/0001019056-05-000840-index.htm
2005-08-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605000931/0001019056-05-000931-index.htm
2005-08-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605000958/0001019056-05-000958-index.htm
2005-10-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001039/0001019056-05-001039-index.htm
2005-11-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001105/0001019056-05-001105-index.htm
2005-11-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001255/0001019056-05-001255-index.htm
2005-12-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001259/0001019056-05-001259-index.htm
2005-12-20425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000101905605001318/0001019056-05-001318-index.htm
2005-12-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001326/0001019056-05-001326-index.htm
2005-12-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001329/0001019056-05-001329-index.htm
2006-01-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905606000002/0001019056-06-000002-index.htm
2006-01-04425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000101905606000004/0001019056-06-000004-index.htm
2006-02-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905606000078/0001019056-06-000078-index.htm
2006-02-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905606000110/0001019056-06-000110-index.htm
2006-02-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905606000133/0001019056-06-000133-index.htm
2019-02-2020-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1333141/000104746919000562/0001047469-19-000562-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746919002820/0001047469-19-002820-index.htm
2019-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746919004442/0001047469-19-004442-index.htm
2019-10-3120-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1333141/000104746919006012/0001047469-19-006012-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746919006013/0001047469-19-006013-index.htm
2020-02-2020-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1333141/000104746920000960/0001047469-20-000960-index.htm
2020-05-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746920002846/0001047469-20-002846-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746920004330/0001047469-20-004330-index.htm
2020-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746920005337/0001047469-20-005337-index.htm
2019-02-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919009478/0001104659-19-009478-index.htm
2019-02-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919009480/0001104659-19-009480-index.htm
2019-02-20IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1333141/000110465919009524/0001104659-19-009524-index.htm
2019-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919009728/0001104659-19-009728-index.htm
2019-02-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919010540/0001104659-19-010540-index.htm
2019-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919014180/0001104659-19-014180-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919019519/0001104659-19-019519-index.htm
2019-04-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919020567/0001104659-19-020567-index.htm
2019-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919024995/0001104659-19-024995-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919026308/0001104659-19-026308-index.htm
2019-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919030697/0001104659-19-030697-index.htm
2019-05-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919031908/0001104659-19-031908-index.htm
2019-05-31SDhttps://www.sec.gov/Archives/edgar/data/1333141/000110465919033034/0001104659-19-033034-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919035489/0001104659-19-035489-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919036076/0001104659-19-036076-index.htm
2019-06-2711-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1333141/000110465919037864/0001104659-19-037864-index.htm
2019-07-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919039891/0001104659-19-039891-index.htm
2019-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919042505/0001104659-19-042505-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919047645/0001104659-19-047645-index.htm
2019-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919057169/0001104659-19-057169-index.htm
2019-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919057180/0001104659-19-057180-index.htm
2019-10-316-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919058403/0001104659-19-058403-index.htm
2019-10-316-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919058428/0001104659-19-058428-index.htm
2019-11-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919066019/0001104659-19-066019-index.htm
2020-02-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920023065/0001104659-20-023065-index.htm
2020-02-20IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1333141/000110465920023280/0001104659-20-023280-index.htm
2020-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920023628/0001104659-20-023628-index.htm
2020-05-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920057373/0001104659-20-057373-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920063458/0001104659-20-063458-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920064025/0001104659-20-064025-index.htm
2020-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920064587/0001104659-20-064587-index.htm
2020-05-29SDhttps://www.sec.gov/Archives/edgar/data/1333141/000110465920067320/0001104659-20-067320-index.htm
2020-06-2611-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1333141/000110465920077497/0001104659-20-077497-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920084339/0001104659-20-084339-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920088067/0001104659-20-088067-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920099294/0001104659-20-099294-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920103698/0001104659-20-103698-index.htm
2020-10-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920114053/0001104659-20-114053-index.htm
2020-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920119245/0001104659-20-119245-index.htm
2005-08-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000132693205000058/0001326932-05-000058-index.htm
2005-11-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000132693205000107/0001326932-05-000107-index.htm
2006-05-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000132693206000162/0001326932-06-000162-index.htm